112234 ⎘
Vectors comprising a targeting moiety Vectors comprising a non-peptidic targeting moiety
ENGINEERED MULTI-COMPONENT SYSTEM FOR IDENTIFICATION AND CHARACTERISATION OF T-CELL RECEPTORS AND T-CELL ANTIGENS
#2ENGINEERING AND OPTIMIZATION OF IMPROVED SYSTEMS, METHODS AND ENZYME COMPOSITIONS FOR SEQUENCE MANIPULATION
#3PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME
#4SYNTHETIC MAMMALIAN SIGNALING CIRCUITS FOR ROBUST CELL POPULATION CONTROL
#5DNA SEQUENCE MODIFICATION-BASED GENE DRIVE
#6PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME
#7VECTORS
#8METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
#9Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#10CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#11Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing
#12MODIFIED ADENO-ASSOCIATED VIRUS VECTORS AND DELIVERY THEREOF INTO THE CENTRAL NERVOUS SYSTEM
#13CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUS
#14Synthetic mammalian signaling circuits for robust cell population control
#15Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#16Use of genomic NW_006882077.1 in CHO cell for stably expressing a protein
#17METHODS FOR ISOLATING CELLS WITHOUT THE USE OF TRANSGENIC MARKER SEQUENCES
#18Modified adeno-associated virus vectors and delivery thereof into the central nervous system
#19MICRORNA REGULATED EXPRESSION VECTORS, METHODS OF MAKING, AND USES THEREOF
#20RNA TRANSCRIPTION VECTOR AND USES THEREOF
#21DNMT3B GENE-DEFICIENT CHO CELL LINE, PREPARATION AND APPLICATIONS THEREOF AND RECOMBINANT PROTEIN EXPRESSION SYSTEM USING THE SAME
#22Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#23Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens
#24Pig genome-wide specific sgRNA library, preparation method therefor and application thereof
#25Methods and compositions for the targeted modification of a genome
#26Plant virus movement proteins and methods of using same
#27METHODS TO IMPROVE PLANT AGRONOMIC TRAIT USING BCS1L GENE AND GUIDE RNA/CAS ENDONUCLEASE SYSTEMS
#28Particles comprising a shell with RNA
#29DNA sequence modification-based gene drive
#30Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#31MITOCHONDRIAL DELIVERY OF RECOMBINANT NUCLEIC ACIDS
#32Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#33Genetically modified non-human animal with human or chimeric LAG-3
#34Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens
#35CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#36CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#37CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#38CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#39Methods and compositions for the targeted modification of a mouse ES cell genome
#40RNA transcription vector and uses thereof
#41Particles comprising a shell with RNA
#42Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#43Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#44METHODS FOR INCREASING THE INFECTIVITY OF VIRUSES
#45Vectors
#46Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#47CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF
#48CNS targeting AAV vectors and methods of use thereof
#49Compositions and methods for modifying cells
#50Plant virus movement proteins and methods of using the same
#51ENGINEERING AND OPTIMIZATION OF IMPROVED SYSTEMS, METHODS AND ENZYME COMPOSITIONS FOR SEQUENCE MANIPULATION
#52GENOME EDITING USING CAS9 NICKASES
#53Methods and compositions for the targeted modification of a mouse embryonic stem cell genome
#54RNA transcription vector and uses thereof
#55Particles comprising a shell with RNA
#56Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#57Dosage compensating transgenes and cells
#58Reduction stimulus-responsive gene delivery system and preparation and application thereof
#59Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
#60Methods and compositions for the targeted modification of a mouse genome
#61Filamentous bacteriophage as an angiogenesis modulator
#62Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#63CNS targeting AAV vectors and methods of use thereof
#64Transpulmonary liposome for controlling drug arrival
#65M13 bacteriophage as a chemoaddressable nanoparticle for biological and medical applications
#66CNS targeting AAV vectors and methods of use thereof
#67Polyconjugates for in vivo delivery of polynucleotides
#68Water-soluble drug carrier and process for producing the same
#69Intracellular viral vector delivery method employing iron ion/viral vector composite
#70MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR
#71Delivery of agents using interfering nanoparticles
#72MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#73MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#74POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY OF OLIGONUCLEOTIDES
#75Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates
#76Modified viral vector particles
#77M13 bacteriophage as a chemoaddressable nanoparticle for biological and medical applications
#78Muller Cell Specific Gene Therapy
#79Protein-coding RNA to correct mitochondrial dysfunction
#80OLIGONUCLEOTIDE SYSTEMS FOR TARGETED INTRACELLULAR DELIVERY
#81Targeting agent for cancer cell or cancer-associated fibroblast
#82Transpulmonary liposome for controlling drug arrival
#83Chimeric alphavirus replicon particles
#84Chimeric alphavirus replicon particles
#85Macrophage transfection method
#86Method for genetically modifying mouse embryonic stem cell by homologous recombination
#87Method for producing retrovirus using human producer cells with increased N-acetylglucosaminyltransferase III activity
#88GENE TRANSFER METHODS
#89Chimeric alphavirus replicon particles
#90Modified viral vector particles
#91Methods of modifying eukaryotic cells
#92Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA